Evidence map›Paper›PMID 35316659›Full record

ArticleMolecular cell2022

Viperin triggers ribosome collision-dependent translation inhibition to restrict viral replication.

Jack Chun-Chieh Hsu, Maudry Laurent-Rolle, Joanna B Pawlak, Hongjie Xia, Amit Kunte, Jia Shee Hee, Jaechul Lim, Lawrence D Harris, James M Wood, Gary B Evans and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 68 citations in OpenAlex.

  1. Palmitic Acid Promotes Antiviral Innate Immunity via ZDHHC20-Mediated CMPK2 Palmitoylation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Viperin and Its Effect on SVCV Replication in Common Carp,Animals : an open access journal from MDPI · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Jack Chun-Chieh HsuDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Maudry Laurent-RolleSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT 06520, USA.
Joanna B PawlakDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Hongjie XiaDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Amit KunteDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Jia Shee HeeDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Jaechul LimDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Lawrence D HarrisThe Ferrier Research Institute, Victoria University of Wellington, Wellington 6012, New Zealand; The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1010, New Zealand.
James M WoodThe Ferrier Research Institute, Victoria University of Wellington, Wellington 6012, New Zealand; The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1010, New Zealand.
Gary B EvansThe Ferrier Research Institute, Victoria University of Wellington, Wellington 6012, New Zealand; The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1010, New Zealand.
Pei-Yong ShiDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Institute for Drug Discovery, Galveston, TX 77555, USA.
Tyler L GroveDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Steven C AlmoDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Peter CresswellDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: peter.cresswell@yale.edu.
Yale University · USAlbert Einstein College of Medicine · USMaurice Wilkins Centre · NZThe University of Texas Medical Branch at Galveston · USVictoria University of Wellington · NZ

Funding

Institutional Career Development CoreKL2TR001862 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$12.2M
Protein/Structure CoreP01GM118303 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI JACOBSON, MATTHEW P · 2016 to 2020
$11.4M
IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
TRAINING IN THE PATHOGENESIS OF INFECTIOUS DISEASEST32AI007517 · NIAID · YALE UNIVERSITY · PI Jaimie Meyer, Albert C Shaw · 1997 to 2026
$6.1M
Molecular Aspects of Human CD1d FunctionsR01AI059167 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2004 to 2019
$5.6M
Quality Control of MHC Class I Restricted Antigen ProcessingR01AI097206 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2012 to 2020
$4.1M
Mechanisms of antigen cross-presentation by MHC class I moleculesR01AI162820 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2021 to 2023
$1.3M
Function and Mechanism of Viperin, a radical SAM antiviral proteinR21AI133329 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ALMO, STEVEN C., GROVE, TYLER L · 2017 to 2018
$459k
NCATS NIH HHS KL2 TR001862NHLBI NIH HHS T32 HL007974NIAID NIH HHS R01 AI059167NIAID NIH HHS R01 AI097206NIAID NIH HHS R01 AI162820NIAID NIH HHS R21 AI133329NIAID NIH HHS T32 AI007517NIGMS NIH HHS P01 GM118303
6 · The paper itself

Abstract

Innate immune responses induce hundreds of interferon-stimulated genes (ISGs). Viperin, a member of the radical S-adenosyl methionine (SAM) superfamily of enzymes, is the product of one such ISG that restricts the replication of a broad spectrum of viruses. Here, we report a previously unknown antiviral mechanism in which viperin activates a ribosome collision-dependent pathway that inhibits both cellular and viral RNA translation. We found that the radical SAM activity of viperin is required for translation inhibition and that this is mediated by viperin's enzymatic product, 3'-deoxy-3',4'-didehydro-CTP (ddhCTP). Viperin triggers ribosome collisions and activates the MAPKKK ZAK pathway that in turn activates the GCN2 arm of the integrated stress response pathway to inhibit translation. The study illustrates the importance of translational repression in the antiviral response and identifies viperin as a translation regulator in innate immunity.

Indexed as

Oxidoreductases Acting on CH-CH Group DonorsProteinsAntiviral AgentsImmunity, InnateRibosomesS-AdenosylmethionineVirus ReplicationAntiviral AgentsOxidoreductases Acting on CH-CH Group DonorsProteinsS-Adenosylmethionineantiviral responseinnate immunityintegrated stress response pathwayinterferon-stimulated geneKunjin virusribosome collisiontranslational regulationviperinZika virus

Identifiers

PMID35316659
PMCPMC9081181
OpenAlexW4220858096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.